These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3016904)
21. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115 [TBL] [Abstract][Full Text] [Related]
22. Problems with AIDS vaccines. Newmark P Nature; 1986 Nov 27-Dec 3; 324(6095):304-5. PubMed ID: 3024011 [No Abstract] [Full Text] [Related]
23. In case of AIDS. Dimond B Nurs Times; 1987 Jun 3-9; 83(22):27-9. PubMed ID: 3037501 [No Abstract] [Full Text] [Related]
24. Education is key to the battle against AIDS. Fisher EJ Mich Med; 1986 Mar; 85(3):98-9. PubMed ID: 3007946 [No Abstract] [Full Text] [Related]
25. HTLV-III: should testing ever be routine? Kinghorn GR Br Med J (Clin Res Ed); 1986 May; 292(6529):1202. PubMed ID: 3011182 [No Abstract] [Full Text] [Related]
26. [Specific antibodies against human T cell leukemia virus found in AIDS patients]. Nagy K; Clapham P; Weiss R; Földes I Orv Hetil; 1984 Jun; 125(26):1557-60. PubMed ID: 6330642 [No Abstract] [Full Text] [Related]
27. [Hospital hygiene. Notice of the Expert Federal Commission for AIDS on procedures to adopt in regard to patients with AIDS and to persons carrying anti-LAV/HTLV-III antibodies]. Krankenpfl Soins Infirm; 1986 May; 79(5):74-5. PubMed ID: 3012197 [No Abstract] [Full Text] [Related]
28. HIV antibodies in intravenous drug abusers. Wodak A; Gold J Med J Aust; 1986 Sep; 145(6):298. PubMed ID: 3018463 [No Abstract] [Full Text] [Related]
29. [Pathogenic retrovirus--current facts and hypotheses]. Kazimierska E Pol Tyg Lek; 1986 Jan; 41(3):86-7. PubMed ID: 3010262 [No Abstract] [Full Text] [Related]
30. So far so good for HIV vaccine. CMAJ; 1997 Jun; 156(12):1692. PubMed ID: 9220914 [No Abstract] [Full Text] [Related]
31. AIDS protein made. Wright K Nature; 1986 Feb 13-19; 319(6054):525. PubMed ID: 3003583 [No Abstract] [Full Text] [Related]
32. AIDS vaccine predictions. Barin F Nature; 1987 Jul 2-8; 328(6125):21. PubMed ID: 3474526 [No Abstract] [Full Text] [Related]
33. Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Robey WG; Arthur LO; Matthews TJ; Langlois A; Copeland TD; Lerche NW; Oroszlan S; Bolognesi DP; Gilden RV; Fischinger PJ Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7023-7. PubMed ID: 3018753 [TBL] [Abstract][Full Text] [Related]
34. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. Sundqvist VA; Linde A; Kurth R; Werner A; Helm EB; Popovic M; Gallo RC; Wahren B J Infect Dis; 1986 May; 153(5):970-3. PubMed ID: 3009638 [No Abstract] [Full Text] [Related]
35. AIDS--aspects of infection control. Jenner EA Midwife Health Visit Community Nurse; 1986 Jun; 22(6):181-4. PubMed ID: 3016487 [No Abstract] [Full Text] [Related]